111 related articles for article (PubMed ID: 25584678)
1. An oncogenic enhancer enemy (N-Me) in T-ALL.
Herranz D; Ferrando AA
Cell Cycle; 2015; 14(2):167-8. PubMed ID: 25584678
[No Abstract] [Full Text] [Related]
2. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
Herranz D; Ambesi-Impiombato A; Palomero T; Schnell SA; Belver L; Wendorff AA; Xu L; Castillo-Martin M; Llobet-Navás D; Cordon-Cardo C; Clappier E; Soulier J; Ferrando AA
Nat Med; 2014 Oct; 20(10):1130-7. PubMed ID: 25194570
[TBL] [Abstract][Full Text] [Related]
3. Thymocyte transformation enhanced.
Pouliot GP; Gutierrez A
Nat Med; 2014 Oct; 20(10):1096-7. PubMed ID: 25295936
[No Abstract] [Full Text] [Related]
4. T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer.
Cancer Discov; 2014 Nov; 4(11):OF17. PubMed ID: 25367958
[TBL] [Abstract][Full Text] [Related]
5. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
[TBL] [Abstract][Full Text] [Related]
6. Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
Antoszewski M; Fournier N; Ruiz Buendía GA; Lourenco J; Liu Y; Sugrue T; Dubey C; Nkosi M; Pritchard CEJ; Huijbers IJ; Segat GC; Alonso-Moreno S; Serracanta E; Belver L; Ferrando AA; Ciriello G; Weng AP; Koch U; Radtke F
Blood; 2022 Apr; 139(16):2483-2498. PubMed ID: 35020836
[TBL] [Abstract][Full Text] [Related]
7. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
Bayer M; Grosschedl R
Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia.
Zhou X; Gu Y; Han Q; Soliman M; Song C; Ge Z
Turk J Haematol; 2017 Dec; 34(4):366-368. PubMed ID: 28747286
[No Abstract] [Full Text] [Related]
9. A Tumor Suppressor Enhancer of
Tottone L; Lancho O; Loh JW; Singh A; Kimura S; Roels J; Kuchmiy A; Strubbe S; Lawlor MA; da Silva-Diz V; Luo S; Gachet S; García-Prieto CA; Hagelaar R; Esteller M; Meijerink JPP; Soulier J; Taghon T; Van Vlierberghe P; Mullighan CG; Khiabanian H; Rocha PP; Herranz D
Blood Cancer Discov; 2021 Jan; 2(1):92-109. PubMed ID: 33458694
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of identical NOTCH1 mutation in non-twinned sisters with T-cell acute lymphoblastic leukemia.
Mansur MB; Ford AM; van Delft FW; Gonzalez D; Emerenciano M; Maia RC; Greaves M; Pombo-de-Oliveira MS
Leukemia; 2011 Aug; 25(8):1368-70. PubMed ID: 21556011
[No Abstract] [Full Text] [Related]
11. Phosphatase PRL2 promotes oncogenic NOTCH1-Induced T-cell leukemia.
Kobayashi M; Bai Y; Chen S; Gao R; Yao C; Cai W; Cardoso AA; Croop J; Zhang ZY; Liu Y
Leukemia; 2017 Mar; 31(3):751-754. PubMed ID: 27872499
[No Abstract] [Full Text] [Related]
12. Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia.
Colomer-Lahiguera S; Strehl S
Leuk Lymphoma; 2016 May; 57(5):1219-22. PubMed ID: 26292904
[No Abstract] [Full Text] [Related]
13. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
14. A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34).
Yamamoto K; Nakamachi Y; Yakushijin K; Miyata Y; Okamura A; Kawano S; Matsuoka H; Minami H
Eur J Haematol; 2013 Jan; 90(1):68-75. PubMed ID: 23033986
[TBL] [Abstract][Full Text] [Related]
15. The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.
Abualhaj NZ; Dardas Z; Azab B; Ali D; Sughayer MA; Aladily TN; Ahram M
Ann Diagn Pathol; 2019 Apr; 39():53-58. PubMed ID: 30718223
[TBL] [Abstract][Full Text] [Related]
16. T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements.
Mansur MB; Emerenciano M; Splendore A; Brewer L; Hassan R; Pombo-de-Oliveira MS;
Leuk Res; 2010 Apr; 34(4):483-6. PubMed ID: 19631984
[TBL] [Abstract][Full Text] [Related]
17. Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
Valliyammai N; Nancy NK; Sagar TG; Rajkumar T
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e1-e8. PubMed ID: 29200162
[TBL] [Abstract][Full Text] [Related]
18. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
Waibel M; Vervoort SJ; Kong IY; Heinzel S; Ramsbottom KM; Martin BP; Hawkins ED; Johnstone RW
Leukemia; 2018 Jan; 32(1):237-241. PubMed ID: 28914259
[No Abstract] [Full Text] [Related]
20. A second NOTCH1 chromosome rearrangement: t(9;14)(q34.3;q11.2) in T-cell neoplasia.
Suzuki S; Nagel S; Schneider B; Chen S; Kaufmann M; Uozumi K; Arima N; Drexler HG; MacLeod RA
Leukemia; 2009 May; 23(5):1003-6. PubMed ID: 19151773
[No Abstract] [Full Text] [Related]
[Next] [New Search]